These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23582914)

  • 1. Pathology - grading and staging of GEP-NETs.
    Capelli P; Fassan M; Scarpa A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended parameters for pathology reporting of gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Malays J Pathol; 2018 Apr; 40(1):79-82. PubMed ID: 29704389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
    Grillo F; Albertelli M; Annunziata F; Boschetti M; Caff A; Pigozzi S; Ferone D; Mastracci L
    Endocrine; 2016 Jul; 53(1):58-62. PubMed ID: 26362059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature.
    Mohamed A; Trybula M; Asa SL; Halfdanarson TR; Sonbol MB
    Endocr Relat Cancer; 2024 Oct; 31(10):. PubMed ID: 39133180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.
    Felder S; Jann H; Arsenic R; Denecke T; Prasad V; Knappe-Drzikova B; Maasberg S; Wiedenmann B; Pavel M; Pascher A; Pape UF
    Endocr Relat Cancer; 2019 Sep; 26(9):751-763. PubMed ID: 31272081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroenteropancreatic neuroendocrine/endocrine tumors. Current pathologic-diagnostic view].
    Schmitt-Gräff A; Nitschke R; Wiedenmann B
    Pathologe; 2001 Mar; 22(2):105-13. PubMed ID: 11321726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
    Karakuş E; Helvacı A; Ekinci O; Dursun A
    Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of neuroendocrine tumors.
    Klöppel G
    Verh Dtsch Ges Pathol; 1997; 81():111-7. PubMed ID: 9474861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent classifications systems for gastroenteropancreatic neuroendocrine tumors A single-center experience.
    Yagmur Y; Söğutcü N; Gümüş S
    Ann Ital Chir; 2020; 91():598-604. PubMed ID: 32989209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.
    Hayes AR; Furnace M; Shah R; Rundell C; Muller G; Dehbi HM; Luong TV; Toumpanakis C; Caplin ME; Krell D; Thirlwell C; Mandair D
    Pancreas; 2021 Apr; 50(4):516-523. PubMed ID: 33939663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours.
    Costa FP; Gumz B; Pasche B
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):843-54. PubMed ID: 23582923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.